GlassScriptPhysician profile
Michael Tyler Scott
NPI 1083903421
$7,417.59
in general payments reported to CMS, 2019-2025
52 companies · $603 in 2025
The $603 reported for 2025 was more than what 78% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,683 · 2020: $237 · 2021: $214 · 2022: $1,993 · 2023: $1,613 · 2024: $1,074 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,290.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,502.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $697.99 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $514.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Seagen INC. | $357.49 | 2020-2023 | Padcev, Adcetris, Tukysa |
| Genzyme Corporation | $339.81 | 2019-2025 | |
| Janssen Biotech, INC. | $324.05 | 2019-2024 | Darzalex, Rybrevant, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $295.52 | 2019-2022 | |
| Daiichi Sankyo INC. | $286.64 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Incyte Corporation | $252.63 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Eisai INC. | $231.17 | 2020-2025 | |
| Puma Biotechnology, INC. | $194.83 | 2020-2025 | |
| Medtronic, INC. | $189.37 | 2022-2023 | Osteocool Rf Ablation System, Intellis Adaptivestim |
| Sirtex Medical INC | $177.00 | 2019-2022 | |
| Lilly USA, LLC | $175.70 | 2022-2024 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $167.81 | 2019 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.